Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waleed Ghanima

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2010
[Immune thrombocytopenia--pathophysiology and treatment]Waleed Ghanima, Pål André Holme, Geir E Tjønnfjord
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2013
[Primary myelofibrosis--pathogenesis, diagnosis and treatment]Waleed Ghanima, Håvar Knutsen, Jan Delabie, et al.
European Journal of Haematology|August 9, 2016
Myeloproliferative neoplasms: trends in incidence, prevalence and survival in NorwayChristina Roaldsnes, René Holst, Henrik Frederiksen, et al.
Expert Review of Hematology|May 10, 2026
Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathwaysAhmed Mjali, Sylvain Audia, Yoshitaka Miyakawa, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 1, 2020
Thromboprophylaxis for patients with COVID-19 infectionEirik Tjønnfjord, Siri Øverstad, Saad Aballi, et al.
Hematological Oncology|April 11, 2017
Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 yearsDlawer Abdulla Barzenje, Arne Kolstad, Waleed Ghanima, et al.
Seminars in Thrombosis and Hemostasis|September 2, 2022
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?Mazdak Tavoly, Elia Asady, Hilde Skuterud Wik, et al.
The Journal of Infection|January 12, 2021
Quality of life after COVID-19 without hospitalisation: Good overall, but reduced in some dimensionsAndrew M Garratt, Waleed Ghanima, Gunnar Einvik, et al.
British Journal of Haematology|August 29, 2023
Refractory immune thrombocytopenia in adults: Towards a new definitionDonald M Arnold, Bianca Clerici, Ekaterina Ilicheva, et al.
Journal of Internal Medicine|July 31, 2023
Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19Birgitte Tholin, Waleed Ghanima, Maria Lie Selle, et al.
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2010
[Immune thrombocytopenia--pathophysiology and treatment]Waleed Ghanima, Pål André Holme, Geir E Tjønnfjord
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2013
[Primary myelofibrosis--pathogenesis, diagnosis and treatment]Waleed Ghanima, Håvar Knutsen, Jan Delabie, et al.
European Journal of Haematology|August 9, 2016
Myeloproliferative neoplasms: trends in incidence, prevalence and survival in NorwayChristina Roaldsnes, René Holst, Henrik Frederiksen, et al.
Expert Review of Hematology|May 10, 2026
Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathwaysAhmed Mjali, Sylvain Audia, Yoshitaka Miyakawa, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 1, 2020
Thromboprophylaxis for patients with COVID-19 infectionEirik Tjønnfjord, Siri Øverstad, Saad Aballi, et al.
Hematological Oncology|April 11, 2017
Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 yearsDlawer Abdulla Barzenje, Arne Kolstad, Waleed Ghanima, et al.
Seminars in Thrombosis and Hemostasis|September 2, 2022
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?Mazdak Tavoly, Elia Asady, Hilde Skuterud Wik, et al.
The Journal of Infection|January 12, 2021
Quality of life after COVID-19 without hospitalisation: Good overall, but reduced in some dimensionsAndrew M Garratt, Waleed Ghanima, Gunnar Einvik, et al.
British Journal of Haematology|August 29, 2023
Refractory immune thrombocytopenia in adults: Towards a new definitionDonald M Arnold, Bianca Clerici, Ekaterina Ilicheva, et al.
Journal of Internal Medicine|July 31, 2023
Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19Birgitte Tholin, Waleed Ghanima, Maria Lie Selle, et al.
Pageof 21